SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-22-003423
Filing Date
2022-05-09
Accepted
2022-05-09 07:00:49
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcrx20220331_10q.htm   iXBRL 10-Q 1286890
2 EXHIBIT 10.1 ex_371288.htm EX-10.1 1512
3 EXHIBIT 10.2 ex_371289.htm EX-10.2 27409
4 EXHIBIT 31.1 ex_366876.htm EX-31.1 15822
5 EXHIBIT 31.2 ex_366877.htm EX-31.2 15820
6 EXHIBIT 32.1 ex_366878.htm EX-32.1 4360
7 EXHIBIT 32.2 ex_366879.htm EX-32.2 4253
13 exh101_01.jpg GRAPHIC 125969
14 exh101_02.jpg GRAPHIC 22573
  Complete submission text file 0001171843-22-003423.txt   6582077

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20220331.xsd EX-101.SCH 68207
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20220331_cal.xml EX-101.CAL 37027
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20220331_def.xml EX-101.DEF 420831
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20220331_lab.xml EX-101.LAB 403219
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20220331_pre.xml EX-101.PRE 442341
59 EXTRACTED XBRL INSTANCE DOCUMENT bcrx20220331_10q_htm.xml XML 931328
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 22903196
SIC: 2836 Biological Products, (No Diagnostic Substances)